The Indian pharmaceutical industry is highly fragmented with about 10,000 manufacturing units (300 in the organized sector). The top ten companies make up for
iv_arti_inline_advt">
more than third of the market. India accounts for about 8% of the world's pharma pie in volume terms, but only 1% in value terms.
Will the recently introduced Patent Regime change all that?